http://www.dana-farber.org/Newsroom/News-Releases/immunotherapy-shows-clinical-benefit-in-relapsed-transplant-recipients.aspx
Posts By: Michelle Chambers
Stem cell transplant without radiation or chemotherapy pre-treatment shows promise
http://www.dana-farber.org/Newsroom/News-Releases/stem-cell-transplant-without-radiation-or-chemotherapy-pre-treatment-shows-promise.aspx
New test developed at Dana-Farber/Brigham and Women’s Cancer Center speeds treatment decisions for blood cancer patients
http://www.dana-farber.org/Newsroom/News-Releases/new-test-developed-at-dana-farber-brigham-and-womens-cancer-center-speeds-treatment-decisions-for-blood-cancer-patients.aspx
Patient’s dramatic response and resistance to cancer drug traced to unsuspected mutations
http://www.dana-farber.org/Newsroom/News-Releases/patients-dramatic-response-and-resistance-to-cancer-drug-traced-to-unsuspected-mutations.aspx
Researchers identify early sign of pancreatic cancer
http://www.dana-farber.org/Newsroom/News-Releases/Researchers-identify-early-sign-of-pancreatic-cancer.aspx
New view of stomach cancer could hasten better therapies
http://www.dana-farber.org/Newsroom/News-Releases/New-view-of-stomach-cancer-could-hasten-better-therapies.aspx
Study identifies novel genomic changes in the most common type of lung cancer
http://www.dana-farber.org/Newsroom/News-Releases/study-identifies-novel-genomic-changes-in-the-most-common-type-of-lung-cancer.aspx
Scientists Engineer Nanoparticles to Prevent Bone Cancer, Strengthen Bones
http://brighamandwomens.org/about_bwh/publicaffairs/news/pressreleases/PressRelease.aspx?sub=0&PageID=1817
Genomic Technology Enters the Mainstream Practice of Medicine
http://brighamandwomens.org/about_bwh/publicaffairs/news/pressreleases/PressRelease.aspx?sub=0&PageID=1815
Many patients with rare gastrointestinal tumor receive long-term benefit from targeted therapy, researchers report
http://www.dana-farber.org/Newsroom/News-Releases/many-patients-with-rare-gastrointestinal-tumor-receive-long-term-benefit-from-targeted-therapy-researchers-report.aspx
Drug-resistant lung tumors respond to new precision therapy in early-stage trial
http://www.dana-farber.org/Newsroom/News-Releases/Drug-resistant-lung-tumors-respond-to-new-precision-therapy-in-early-stage-trial.aspx
FDA approves first targeted drug for advanced stomach cancer
http://www.dana-farber.org/Newsroom/News-Releases/fda-approves-first-targeted-drug-for-advanced-stomach-cancer.aspx
Genomic testing links ‘exceptional’ drug response to rare mutations in bladder cancer
http://www.dana-farber.org/Genomic-testing-links-exceptional-drug-response-to-rare-mutations-bladder-cancer.aspx
Study reports success in targeted therapy for common form of lung cancer
http://www.dana-farber.org/Newsroom/News-Releases/Study-reports-success-in-targeted-therapy-for-common-form-of-lung-cancer.aspx
Some patients with incurable tumors and BRCA mutations respond to new two-drug combination
http://www.dana-farber.org/Newsroom/News-Releases/some-patients-with-incurable-tumors-and-brca-mutations-respond-to-new-two-drug-combination.aspx
Find Clinical Trials
To find clinical trials that focus on targeted therapies, use the pulldown menus below or enter a term in the search box.
Request a Consultation
To schedule a consultation with an oncologist at Dana-Farber/Brigham and Women's Cancer Center, please call one of our experienced appointment coordinators.
